~~<i id='4E822D7F2D'><strike id='4E822D7F2D'><tt id='4E822D7F2D'><pre id='4E822D7F2D'></pre></tt></strike></i>~~

Home» comprehensive» Wikipedia

Wikipedia

author：knowledge 2025-09-28 16:21:50 Page View：1

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Lilly’s obesity pill cuts 15% of weight at highest dose in mid
Next article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

comprehensive

United colonoscopy coverage change 'may cost lives,' doctors say

AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

FILE-HandgunsaredisplayedatagunshoponJune,23,2022,inHonolulu.ThreeHawaiiresidentschallengingthestate

Medical records are filled with copy

AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

Here's how to stay safe from wildfire smoke amid reduced air quality

1:54ApersonwearingafacemaskwalksnearaviewofthetheEmpireStateBuildingduringheavysmoginNewYorkonJune6,